Home Page ::: Current Medicinal Chemistry

ISSN: 1875-533X (Online)
ISSN: 0929-8673 (Print)


Volume 21, 38 Issues, 2014


Download PDF Flyer




Current Medicinal Chemistry

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 9th of 58 in

    Chemistry & Medicinal

  • 49th of 254 in

    Pharmacology & Pharmacy

  • 96th of 291 in

    Biochemistry & Molecular Biology


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

Atta-ur-Rahman

, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK
Email: cmc@benthamscience.org

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.715
5 - Year: 4.239
Announcements



SCImago Journal Ranking

SCImago Journal & Country Rank

Endorsement(s)

“《当今医药化学》是一本信息量很大且很有价值的期刊,我已经阅读这本期刊很多年了,受益良多,我向所有医药化学界的研究人员强烈推荐此期刊。”

展鹏 博士
化学生物学重点实验室医药化学部(教育部,中国山东省济南市文化西路44号山东大学药学院 250012

Forthcoming Special Issue(s)

Women and Cardiovascular Disease


Guest Editor(s): Genovefa Kolovou, Dimitri P. Mikhailidis, Niki Katsiki
Tentative Publication Date: April, 2015
Submit Abstract via Email Download Description
Special Issue(s) - In-Press

Natural polyphenols and diabetes: Understanding their Mechanism of Action?


Guest Editor(s): Jianbo Xiao
Submit Abstract via Email Download Description
Published Special Issue(s)

Neuronanomedicine


Guest Editor(s): Eng-Ang Ling , Ong Wei Yi
Download Description
Authors' Comments
Publishing with Bentham in my experience has always been a great pleasure; I never had problems or unnecessary delays, and regarding the points raised by the Referee's .Even if they required a lot of changes, it always led to an improvement in the manuscript quality; thus, a special thanks for the referee's work and quality.
I would also like to appreciate the Editor of the journal, as he was able to select competent people for this crucial task.
Additionally, it is always a pleasure to read articles published in Current Medicinal Chemistry; owing to their quality and the up-to-date topics .Current Medicinal Chemistry is one of the few journals that I check every month. In particular, my last submission is of interest for both pharmaceutical and biomedical industry.”

Dr. L. Costantino
Has contributed: Challenges in the Design of Clinically Useful Brain-targeted Drug Nanocarriers

Current Medicinal Chemistry

,

Volume 21

-

Number 36



Diagnostic and Therapeutic Uses of Nanomaterials in the Brain

; Pp: 4100 - 4131

Elisa Garbayo, Ander Estella-Hermoso de Mendoza and Maria J. Blanco-Prieto


DOI: 10.2174/0929867321666140815124246
View Abstract Purchase Online Rights and Permissions

  
  



Colloidal Supramolecular Aggregates for Therapeutic Application in Neuromedicine

; Pp: 4132 - 4153

Donato Cosco, Luisa Di Marzio, Carlotta Marianecci, Elena Trapasso, Donatella Paolino, Christian Celia, Maria Carafa and Massimo Fresta


DOI: 10.2174/0929867321666140826113933
View Abstract Purchase Online Rights and Permissions

  
  



Nanotechnology and Alzheimer’s Disease: What has been Done and What to Do’

; Pp: 4169 - 4185

B. Ruozi, D. Belletti, F. Pederzoli, P. Veratti, F. Forni, M.A. Vandelli and G. Tosi


DOI: 10.2174/0929867321666140716100056
View Abstract Purchase Online Rights and Permissions

  
  



Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies

; Pp: 4186 - 4198

Benson J. Edagwa, Tian Zhou, JoEllyn M. McMillan, Xin-Ming Liu and Howard E. Gendelman


DOI: 10.2174/0929867321666140826114135
View Abstract Purchase Online Rights and Permissions

  
  



Smoking and Atherosclerosis: Mechanisms of Disease and New Therapeutic Approaches


Gerasimos Siasos, Dimitris Tousoulis, Stavroula Michalea, Evangelos Oikonomou, Manolis Vavuranakis, Dimitris Athanasiou, Panagiotis Tourikis, Nikolaos Gouliopoulos, Antigoni Miliou, Savvas Mazaris, Athanasios G. Papavassiliou and Christodoulos Stefanadis


View Abstract Purchase Online

  
  


Reactive Metabolites in Early Drug Development: Predictive in Vitro Tools


Olavi Pelkonen, Markku Pasanen, Ari Tolonen, Mikko Koskinen, Jukka Hakkola, Khaled Abass, Jaana Laine, Merja Häkkinen, Risto Juvonen, Seppo Auriola, Markus Storvik, Pasi Huuskonen, Timo Rousu and Maiju Rahikkala


View Abstract

  
  


Vascular and Metabolic Actions of the Green Tea Polyphenol Epigallocatechin Gallate


Michelle A. Keske, Huei L.H. Ng, Dino Premilovac, Stephen Rattigan, Jeong -a Kim, Kashif Munir, Peixin Yang and Michael J. Quon


View Abstract

  
  


P2X Receptors and Diabetes


Carmen Fotino, Andrea Vergani, Paolo Fiorina and Antonello Pileggi


View Abstract

  
  


Emerging Roles of P2X Receptors in Cancer


Elena Adinolfi, Marina Capece, Francesca Amoroso, Elena De Marchi and Alessia Franceschini


View Abstract

  
  


Chemistry and Biology of Pyoverdines, Pseudomonas Primary Siderophores


Christine Cézard, Natacha Farvacques and Pascal Sonnet


View Abstract

  
  


NMR in the Design of Antibacterials


Emilija Arsovska, Anamarija Zega, Gregor Mali and Simona Golic Grdadolnik


View Abstract

  
  


Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases

, 2014 :21(35); 4046 - 4058

Federico Carbone, Francois Mach, Nicolas Vuilleumier and Fabrizio Montecucco


DOI: 10.2174/0929867321666140915141332
View Abstract Purchase Online Rights and Permissions

  
  


Pharmacophore and Binding Analysis of Known and Novel B-RAF Kinase Inhibitors

, 2014 :21(17); 1938 - 1955

F. Baska, I. Szabadkai, A. Sipos, N. Breza, C. Szantai-Kis, L. Kekesi, R. Garamvolgyi, Z. Nemes, F. Baska, L. Neumann, R. Torka, A. Ullrich, G. Keri and L. Orfi


DOI: 10.2174/0929867321666140304152606
View Abstract Purchase Online Rights and Permissions

  
  


HIV-Antigens Charged on Phosphorus Dendrimers as Tools for Tolerogenic Dendritic Cells-Based Immunotherapy

, 2014 :21(16); 1898 - 1909

Enrique Vacas-Cordoba, Hugo Bastida, Marjorie Pion, Aurelien Hameau, Maksim Ionov, Maria Bryszewska, Anne Marie Caminade, Jean Pierre Majoral and Maria-Angeles Munoz-Fernandez


DOI: 10.2174/0929867321666131129114022
View Abstract Purchase Online Rights and Permissions

  
  


Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A

, 2014 :21(12); 1391 - 1404

I. Gentile, F. Borgia, N. Coppola, A.R. Buonomo, G. Castaldo and G. Borgia


DOI: 10.2174/0929867321666131228222215
View Abstract Purchase Online Rights and Permissions

  
  


Advertisement

Related Journals




Related eBooks


Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science